Control of the autoimmune response by type 2 nitric oxide synthase

Area of Science:

• Immunology
• Autoimmunity
• Neuroimmunology

Background:

• Immune defense against pathogens often involves nitric oxide (NO) synthesized by type 2 NO synthase (NOS2).
• The role of NOS2 in autoimmune diseases remains incompletely understood.
• Myasthenia gravis is a T cell-dependent, antibody-mediated autoimmune disease affecting neuromuscular junctions.

Purpose of the Study:

• To investigate the role of NOS2 in the development and progression of experimental autoimmune myasthenia gravis (EAMG).
• To determine if the NOS2/NO axis influences autoreactive T cell responses and autoantibody production in EAMG.

Main Methods:

• Immunization of NOS2-deficient and wild-type mice with acetylcholine receptor (AChR) autoantigen.
• Assessment of clinical EAMG severity (muscle weakness).
• Analysis of T cell determinant spreading and autoantibody repertoire diversification, with a focus on macrophage involvement.

Main Results:

• NOS2-deficient mice exhibited an exacerbated form of myasthenia gravis compared to wild-type controls.
• NOS2 deficiency led to increased autoreactive T cell determinant spreading.
• Diversification of the autoantibody repertoire was enhanced in NOS2-deficient mice, driven by macrophages.

Conclusions:

• NOS2/NO plays a critical role in limiting autoimmune responses, specifically in EAMG.
• NOS2 is important for suppressing autoreactive T cells and restricting bystander autoimmune reactions.
• Macrophage-mediated processes are involved in NOS2's regulatory function in autoimmunity.